Ziccum AB (publ) (ZICC.ST) Research

Ziccum AB (publ) specializes in creating stable dry powder formulations for biological pharmaceuticals. The company's core offering is LaminarPace, a proprietary spray drying technology they develop and commercialize. This innovative system enables the gentle, room-temperature drying of diverse substances, including chemicals, vaccines, biologics, and various other drug compounds. Established in 2017, Ziccum maintains its headquarters in Lund, Sweden.

Market snapshot

Symbol
ZICC.ST
Price
$0.25
Day change
0.00%
Market cap
$8.6M
P/E ratio
-0.16x
52-week range
0.25-0.393
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Amniotics AB (publ) (AMNI.ST)
  • Bonzun AB (publ) (BONZUN.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Hemcheck Sweden AB (publ) (HEMC.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Learning 2 Sleep L2S AB (publ) (L2S.ST)
  • Pexa AB (PEXAB.ST)
  • Pharmiva AB (publ) (PHARM.ST)

Open Ziccum AB (publ) (ZICC.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.